Overview Effects of Lomitapide on Carotid and Aortic Atherosclerosis Status: Withdrawn Trial end date: 2021-12-01 Target enrollment: Participant gender: Summary Study to assess changes in carotid and aortic atherosclerosis in patients being treated with lomitapide. Details Lead Sponsor: Aegerion Pharmaceuticals, Inc.